1 study found for:    20479410 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Doxorubicin and Cyclophosphamide Followed by Paclitaxel, Trastuzumab, and Lapatinib in Treating Patients With HER2/Neu-Overexpressed Breast Cancer
Condition: Breast Cancer
Interventions: Biological: trastuzumab;   Drug: cyclophosphamide;   Drug: doxorubicin hydrochloride;   Drug: lapatinib ditosylate;   Drug: paclitaxel;   Other: laboratory biomarker analysis

Indicates status has not been verified in more than two years